ARE vs PRME · P/E 100, rev $662.8M vs rev $4.6M
Alexandria Real Estate Equities Inc (ARE) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Alexandria Real Estate Equities Inc (ARE) is a reit - office company listed on US.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported ARE revenue for 2026-06-30 was $662.8M. Net income was -$72.8M. Revenue was down 1.2% from 2026-03-31 to 2026-06-30. ARE currently screens at market cap $13.19B and trailing P/E 100.4.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
ARE currently screens at market cap $13.19B and trailing P/E 100.4. PRME currently screens at market cap $570.8M.
Not investment advice. Open the ARE and PRME stock pages for the full models.
Not investment advice.